Gongdong Medical released its 2026 half-year report. First-half non-GAAP net profit attributable to the parent was 53.07 million yuan, down 11.2% year-on-year. Operating revenue was 588 million yuan, up 5.6% year-on-year. Net profit attributable to the parent was 54.69 million yuan, up 8.6% year-on-year. Net operating cash flow was 130 million yuan, up 45.2% year-on-year. Second-quarter operating revenue was 299 million yuan, up 2.4% year-on-year, and net profit attributable to the parent was 22.7 million yuan, down 1.0% year-on-year. The company's main business is the research, development, production and sales of disposable medical consumables. Management said business optimization implemented for the TPI segment led to a significant recovery in profitability.
Zhejiang Gongdong Medical Technology Co LtdFirst-half non-GAAP net profit fell 11.2% year-on-year, though reported net profit rose 8.6%.
